-
1
-
-
0024334658
-
Coagulation, fibrinolysis, and kallikrein systems in sepsis: Relation to outcome
-
Hesselvik JF, Blombäck M, Brodin B, Maller R. Coagulation, fibrinolysis, and kallikrein systems in sepsis: relation to outcome. Crit Care Med 1989;17:724-733
-
(1989)
Crit Care Med
, vol.17
, pp. 724-733
-
-
Hesselvik, J.F.1
Blombäck, M.2
Brodin, B.3
Maller, R.4
-
2
-
-
0025262314
-
Activation and inhibition of fibrinolysis in septic patients in an internal intensive care unit
-
Voss R, Matthias FR, Borkowski G, Reitz D. Activation and inhibition of fibrinolysis in septic patients in an internal intensive care unit. Br J Haematol 1990;75:99-105
-
(1990)
Br J Haematol
, vol.75
, pp. 99-105
-
-
Voss, R.1
Matthias, F.R.2
Borkowski, G.3
Reitz, D.4
-
3
-
-
0026534242
-
Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies
-
Fourrier F, Chopin C, Goudemand J, et al. Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies. Chest 1992;101:816-823
-
(1992)
Chest
, vol.101
, pp. 816-823
-
-
Fourrier, F.1
Chopin, C.2
Goudemand, J.3
-
4
-
-
0027214771
-
Time course of hemostatic abnormalities in sepsis and its relation to outcome
-
Lorente JA, García-Frade LJ, Landin L, et al. Time course of hemostatic abnormalities in sepsis and its relation to outcome. Chest 1993;103:1536-1542
-
(1993)
Chest
, vol.103
, pp. 1536-1542
-
-
Lorente, J.A.1
García-Frade, L.J.2
Landin, L.3
-
5
-
-
0030100155
-
Alterations in coagulation and fibrinolysis during sepsis
-
Kidokoro A, Iba T, Fukunaga M, Yagi Y. Alterations in coagulation and fibrinolysis during sepsis. Shock 1996;5:223-228
-
(1996)
Shock
, vol.5
, pp. 223-228
-
-
Kidokoro, A.1
Iba, T.2
Fukunaga, M.3
Yagi, Y.4
-
7
-
-
0024419991
-
The quantitative association of plasma endotoxin, antithrombin, protein C, extrinsic pathway inhibitor and fibrinopeptide A in systemic meningococcal disease
-
Brandtzaeg P, Sandset PM, Joø GB, Øvstebo R, Abildgaard U, Kierulf P. The quantitative association of plasma endotoxin, antithrombin, protein C, extrinsic pathway inhibitor and fibrinopeptide A in systemic meningococcal disease. Thromb Res 1989;55:459-470
-
(1989)
Thromb Res
, vol.55
, pp. 459-470
-
-
Brandtzaeg, P.1
Sandset, P.M.2
Joø, G.B.3
Øvstebo, R.4
Abildgaard, U.5
Kierulf, P.6
-
8
-
-
0028855106
-
Coagulation activation and tissue necrosis in meningococcal septic shock: Severely reduced protein C levels predict a high mortality
-
Fijnvandraat K, Derkx B, Peters M, et al. Coagulation activation and tissue necrosis in meningococcal septic shock: severely reduced protein C levels predict a high mortality. Thromb Haemostas 1995;73:15-20
-
(1995)
Thromb Haemostas
, vol.73
, pp. 15-20
-
-
Fijnvandraat, K.1
Derkx, B.2
Peters, M.3
-
9
-
-
0026016470
-
Treatment of gram-negative bacteremia and septic shock with HA-IA human monoclonal antibody against endotoxin
-
Ziegler KJ, Fisher CJ, Sprung CL, et al. Treatment of gram-negative bacteremia and septic shock with HA-IA human monoclonal antibody against endotoxin. N Engl J Med 1991;324: 429-436
-
(1991)
N Engl J Med
, vol.324
, pp. 429-436
-
-
Ziegler, K.J.1
Fisher, C.J.2
Sprung, C.L.3
-
10
-
-
0025917510
-
A controlled clinical trial of E5 Murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis
-
Greenman RL, Schein RMH, Martin MA, et al. A controlled clinical trial of E5 Murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. JAMA 1991; 266:1097-1102
-
(1991)
JAMA
, vol.266
, pp. 1097-1102
-
-
Greenman, R.L.1
Schein, R.M.H.2
Martin, M.A.3
-
11
-
-
0028239555
-
Recombinant human Interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome
-
Fisher CJ, Dhainaut JFA, Opal SM, et al. Recombinant human Interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. JAMA 1994;271:1836-1843
-
(1994)
JAMA
, vol.271
, pp. 1836-1843
-
-
Fisher, C.J.1
Dhainaut, J.F.A.2
Opal, S.M.3
-
12
-
-
0028957549
-
Efficacy and safety of monoclonal antibody to human tumor necrosis factor α in patients with sepsis syndrome
-
Abraham E, Wunderink R, Silverman H, et al. Efficacy and safety of monoclonal antibody to human tumor necrosis factor α in patients with sepsis syndrome. JAMA 1995;273: 934-941
-
(1995)
JAMA
, vol.273
, pp. 934-941
-
-
Abraham, E.1
Wunderink, R.2
Silverman, H.3
-
13
-
-
0029043636
-
A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: Results of a prospective, multicenter, randomized, controlled trial
-
Bone RC, Balk RA, Fein AM, et al. A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: Results of a prospective, multicenter, randomized, controlled trial. Crit Care Med 1995;23:994-1005
-
(1995)
Crit Care Med
, vol.23
, pp. 994-1005
-
-
Bone, R.C.1
Balk, R.A.2
Fein, A.M.3
-
14
-
-
0029835023
-
INTERSEPT: An international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-α in patients with sepsis
-
Cohen J, Carlet J, Intersept study group. INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-α in patients with sepsis. Crit Care Med 1996;24:1431-1440
-
(1996)
Crit Care Med
, vol.24
, pp. 1431-1440
-
-
Cohen, J.1
Carlet, J.2
-
15
-
-
0028893025
-
The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study
-
Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 1995;273:117-123
-
(1995)
JAMA
, vol.273
, pp. 117-123
-
-
Rangel-Frausto, M.S.1
Pittet, D.2
Costigan, M.3
Hwang, T.4
Davis, C.S.5
Wenzel, R.P.6
-
16
-
-
0025904459
-
Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody
-
Taylor Jr FB, Chang A, Ruf W, et al. Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody. Circ Shock 1991;33:127-134
-
(1991)
Circ Shock
, vol.33
, pp. 127-134
-
-
Taylor Jr., F.B.1
Chang, A.2
Ruf, W.3
-
17
-
-
0028006127
-
Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees
-
Levi M, ten Cate H, Bauer KA, et al. Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees. J Clin Invest 1994;93:114-120
-
(1994)
J Clin Invest
, vol.93
, pp. 114-120
-
-
Levi, M.1
Ten Cate, H.2
Bauer, K.A.3
-
18
-
-
0028895452
-
Complete inhibition of endotoxin-induced coagulation activation in chimpanzees with a monoclonal Fab fragment against factor VII/VIIa
-
Biemond BJ, ten Cate H, Levi M, et al. Complete inhibition of endotoxin-induced coagulation activation in chimpanzees with a monoclonal Fab fragment against factor VII/VIIa. Thromb Haemostas 1995;73:223-230
-
(1995)
Thromb Haemostas
, vol.73
, pp. 223-230
-
-
Biemond, B.J.1
Ten Cate, H.2
Levi, M.3
-
19
-
-
0027319678
-
Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock
-
Creasey AA, Chang ACK, Feigen L, Wün TC, Taylor Jr FB, Hinshaw LB. Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock. J Clin Invest 1993; 91:2850-2860
-
(1993)
J Clin Invest
, vol.91
, pp. 2850-2860
-
-
Creasey, A.A.1
Chang, A.C.K.2
Feigen, L.3
Wün, T.C.4
Taylor Jr., F.B.5
Hinshaw, L.B.6
-
20
-
-
0028627767
-
Recombinant E. coli-derived tissue factor pathway inhibitor reduces coagulopathic and lethal effects in the baboon Gram-negative model of septic shock
-
Carr C, Bild GS, Chang ACK, et al. Recombinant E. coli-derived tissue factor pathway inhibitor reduces coagulopathic and lethal effects in the baboon Gram-negative model of septic shock. Circ Shock 1995;44:126-137
-
(1995)
Circ Shock
, vol.44
, pp. 126-137
-
-
Carr, C.1
Bild, G.S.2
Chang, A.C.K.3
-
21
-
-
0025647250
-
Experimemal endotoxemia in humans: Analysis of cytokine release and coagulation, fibrinolytic and complement pathways
-
Van Deventer SJH, Büller HR, Ten Cate JW, Aarden LA, Hack CE, Sturk A. Experimemal endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic and complement pathways. Blood 1990;76:2520-2526
-
(1990)
Blood
, vol.76
, pp. 2520-2526
-
-
Van Deventer, S.J.H.1
Büller, H.R.2
Ten Cate, J.W.3
Aarden, L.A.4
Hack, C.E.5
Sturk, A.6
-
22
-
-
0000677036
-
Dose-dependent endotoxin-induced cytokine release and coagulation activation in chimpanzees
-
Levi M, ten Cate H, Bauer EKA, Büller HR, ten Cate JW, Rosenberg RD. Dose-dependent endotoxin-induced cytokine release and coagulation activation in chimpanzees. Thromb Haemostas 1991;65:793
-
(1991)
Thromb Haemostas
, vol.65
, pp. 793
-
-
Levi, M.1
Ten Cate, H.2
Bauer, E.K.A.3
Büller, H.R.4
Ten Cate, J.W.5
Rosenberg, R.D.6
-
23
-
-
0027469403
-
The contact system contributes to hypotension but not to disseminated intravascular coagulation in lethal bacteremia
-
Pixley RA, DeLa Cadena R, Page JD, et al. The contact system contributes to hypotension but not to disseminated intravascular coagulation in lethal bacteremia. J Clin Invest 1993; 91:61-68
-
(1993)
J Clin Invest
, vol.91
, pp. 61-68
-
-
Pixley, R.A.1
DeLa Cadena, R.2
Page, J.D.3
-
24
-
-
0027598934
-
Disseminated intravascular coagulation: Pathophysiology, diagnosis, and treatment
-
Ten Cate H, Brandjes DPM, Wolters HJ, Van Deventer SJH. Disseminated intravascular coagulation: pathophysiology, diagnosis, and treatment. New Horizons 1993;1:312-323
-
(1993)
New Horizons
, vol.1
, pp. 312-323
-
-
Ten Cate, H.1
Brandjes, D.P.M.2
Wolters, H.J.3
Van Deventer, S.J.H.4
-
25
-
-
0024308270
-
Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin
-
Gregory SA, Morrissey JH, Edgington TS. Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin. Mol Cell Biol 1989;9:2752-2755
-
(1989)
Mol Cell Biol
, vol.9
, pp. 2752-2755
-
-
Gregory, S.A.1
Morrissey, J.H.2
Edgington, T.S.3
-
26
-
-
0020658537
-
Increased tissue thromboplastin activity in monocytes of patients with meningococcal infection: Related to an unfavourable prognosis
-
Østerud B, Flægstad T. Increased tissue thromboplastin activity in monocytes of patients with meningococcal infection: related to an unfavourable prognosis. Thromb Haemostas 1983; 49:5-7
-
(1983)
Thromb Haemostas
, vol.49
, pp. 5-7
-
-
Østerud, B.1
Flægstad, T.2
-
27
-
-
0023089665
-
Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro
-
Moore KL, Andreoli SP, Esmon NL, Esmon CT, Bang NU. Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro. J Clin Invest 1987;79:124-130
-
(1987)
J Clin Invest
, vol.79
, pp. 124-130
-
-
Moore, K.L.1
Andreoli, S.P.2
Esmon, N.L.3
Esmon, C.T.4
Bang, N.U.5
-
28
-
-
0020554745
-
Cultured human endothelial cells generate tissue factor in response to endotoxin
-
Colucci M, Balconi G, Lorenzet R, et al. Cultured human endothelial cells generate tissue factor in response to endotoxin. J Clin Invest 1983;71:1893-1896
-
(1983)
J Clin Invest
, vol.71
, pp. 1893-1896
-
-
Colucci, M.1
Balconi, G.2
Lorenzet, R.3
-
29
-
-
0021242251
-
Tissue factor-dependent activation of tritium-labeled factor IX and factor X in human plasma
-
Morrison SA, Jesty J. Tissue factor-dependent activation of tritium-labeled factor IX and factor X in human plasma. Blood 1984;63:1338-1347
-
(1984)
Blood
, vol.63
, pp. 1338-1347
-
-
Morrison, S.A.1
Jesty, J.2
-
30
-
-
0027123107
-
Molecular and cellular biology of blood coagulation
-
Furie B, Furie BC. Molecular and cellular biology of blood coagulation. N Engl J Med 1992;326:800-806
-
(1992)
N Engl J Med
, vol.326
, pp. 800-806
-
-
Furie, B.1
Furie, B.C.2
-
31
-
-
0027312189
-
Hemostatic study before onset of disseminated intravascular coagulation
-
Wada H, Minamikawa K, Wakita Y, et al. Hemostatic study before onset of disseminated intravascular coagulation. Am J Hematol 1993;43:190-194
-
(1993)
Am J Hematol
, vol.43
, pp. 190-194
-
-
Wada, H.1
Minamikawa, K.2
Wakita, Y.3
-
32
-
-
0021133167
-
Acceleration of thrombin-antithrombin complex formation in rat hindquarters via heparin-like molecules bound to the endothelium
-
Marcum JA, McKenney JB, Rosenberg RD. Acceleration of thrombin-antithrombin complex formation in rat hindquarters via heparin-like molecules bound to the endothelium. J Clin Invest 1984;74:341-350
-
(1984)
J Clin Invest
, vol.74
, pp. 341-350
-
-
Marcum, J.A.1
McKenney, J.B.2
Rosenberg, R.D.3
-
33
-
-
0025051259
-
Human recombinant interleukin 1-beta and tumor necrosis factor alfa-mediated suppression of heparin-like compounds on cultured porcine aortic endothelial cells
-
Kobayashi M, Shimada K, Ozawa T. Human recombinant interleukin 1-beta and tumor necrosis factor alfa-mediated suppression of heparin-like compounds on cultured porcine aortic endothelial cells. J Cell Physiol 1990;144:383-390
-
(1990)
J Cell Physiol
, vol.144
, pp. 383-390
-
-
Kobayashi, M.1
Shimada, K.2
Ozawa, T.3
-
34
-
-
0026690665
-
Cloned platelet thrombin receptor is necessary for thrombin-induced platelet activation
-
Hung DT, Vu TKH, Wheaton VI, Ishii K, Coughlin SR. Cloned platelet thrombin receptor is necessary for thrombin-induced platelet activation. J Clin Invest 1992;89:1350-1353
-
(1992)
J Clin Invest
, vol.89
, pp. 1350-1353
-
-
Hung, D.T.1
Vu, T.K.H.2
Wheaton, V.I.3
Ishii, K.4
Coughlin, S.R.5
-
35
-
-
0022000553
-
Protein S is required for bovine platelets to support activated protein C binding and activity
-
Harris KW, Esmon CT. Protein S is required for bovine platelets to support activated protein C binding and activity. J Biol Chem 1985;260:2007-2011
-
(1985)
J Biol Chem
, vol.260
, pp. 2007-2011
-
-
Harris, K.W.1
Esmon, C.T.2
-
36
-
-
0019166796
-
Deficiency of protein C inhibitor in combined factor V/VIII deficiency disease
-
Marlar RA, Griffin JH. Deficiency of protein C inhibitor in combined factor V/VIII deficiency disease. J Clin Invest 1980;66:1186-1189
-
(1980)
J Clin Invest
, vol.66
, pp. 1186-1189
-
-
Marlar, R.A.1
Griffin, J.H.2
-
38
-
-
0024437911
-
Evidence that C4b-binding protein is an acute phase protein
-
Saeki T, Hirose S, Nukatsuka M, Kusunoki Y, Nagasawa S. Evidence that C4b-binding protein is an acute phase protein. Biochem Biophys Res Commun 1989;164:1446-1451
-
(1989)
Biochem Biophys Res Commun
, vol.164
, pp. 1446-1451
-
-
Saeki, T.1
Hirose, S.2
Nukatsuka, M.3
Kusunoki, Y.4
Nagasawa, S.5
-
39
-
-
0025769689
-
The extrinsic pathway inhibitor: A regulator of tissue factor-dependent blood coagulation
-
Rapaport SI. The extrinsic pathway inhibitor: a regulator of tissue factor-dependent blood coagulation. Thromb Haemostas 1991;66:6-15
-
(1991)
Thromb Haemostas
, vol.66
, pp. 6-15
-
-
Rapaport, S.I.1
-
40
-
-
0026764143
-
The role of tissue factor pathway inhibitor in a revised coagulation cascade
-
Broze GJ Jr. The role of tissue factor pathway inhibitor in a revised coagulation cascade. Semin Hematol 1992;29:159-169
-
(1992)
Semin Hematol
, vol.29
, pp. 159-169
-
-
Broze Jr., G.J.1
-
41
-
-
0024543984
-
Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor
-
Girard TJ, Warren LA, Novotny WF, et al. Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor. Nature 1989;338:518-520
-
(1989)
Nature
, vol.338
, pp. 518-520
-
-
Girard, T.J.1
Warren, L.A.2
Novotny, W.F.3
-
42
-
-
0023757465
-
Antithrombin-III prevents the lethal effects of Escherichia coli infusion in baboons
-
Taylor Jr FB, Emerson Jr TE, Jordan R, Chang AK, Blick KE. Antithrombin-III prevents the lethal effects of Escherichia coli infusion in baboons. Circ Shock 1988;26:227-235
-
(1988)
Circ Shock
, vol.26
, pp. 227-235
-
-
Taylor Jr., F.B.1
Emerson Jr., T.E.2
Jordan, R.3
Chang, A.K.4
Blick, K.E.5
-
43
-
-
0023122016
-
Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in baboons
-
Taylor Jr FB, Chang A, Esmon CT, D'Angelo A, Vigano-D'Angelo S, Blick KE. Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in baboons. J Clin Invest 1987;79:918-925
-
(1987)
J Clin Invest
, vol.79
, pp. 918-925
-
-
Taylor Jr., F.B.1
Chang, A.2
Esmon, C.T.3
D'Angelo, A.4
Vigano-D'Angelo, S.5
Blick, K.E.6
-
44
-
-
0025835094
-
C4b-binding protein exacerbates the host response to Escherichia coli
-
Taylor F, Chang A, Ferrel G, et al. C4b-binding protein exacerbates the host response to Escherichia coli. Blood 1991;78: 357-363
-
(1991)
Blood
, vol.78
, pp. 357-363
-
-
Taylor, F.1
Chang, A.2
Ferrel, G.3
-
46
-
-
0023912918
-
Cytokine appearance in human endotoxemia and primate bacteremia
-
Hesse DG, Tracey KJ, Fong Y, et al. Cytokine appearance in human endotoxemia and primate bacteremia. Surg Gynecol Obstet 1988;166:147-153
-
(1988)
Surg Gynecol Obstet
, vol.166
, pp. 147-153
-
-
Hesse, D.G.1
Tracey, K.J.2
Fong, Y.3
-
47
-
-
0025829450
-
Detection of interleukin-8 and tumor necrosis factor in normal humans following intravenous endotoxin: The effect of anti-inflammatory agents
-
Mastich GD, Danner RL, Ceska M, Suffredini AF. Detection of interleukin-8 and tumor necrosis factor in normal humans following intravenous endotoxin: the effect of anti-inflammatory agents. J Exp Med 1991;173:1021-1024
-
(1991)
J Exp Med
, vol.173
, pp. 1021-1024
-
-
Mastich, G.D.1
Danner, R.L.2
Ceska, M.3
Suffredini, A.F.4
-
48
-
-
0024822793
-
Antibodies to cachectin/tumor necrosis factor reduce interleukin-1β and interleukin-6 appearance during lethal bacteremia
-
Fong Y, Tracey KJ, Moldawer LL, et al. Antibodies to cachectin/tumor necrosis factor reduce interleukin-1β and interleukin-6 appearance during lethal bacteremia. J Exp Med 1989;170:1627-1633
-
(1989)
J Exp Med
, vol.170
, pp. 1627-1633
-
-
Fong, Y.1
Tracey, K.J.2
Moldawer, L.L.3
-
49
-
-
0025768566
-
Plasma neutrophil-activating peptide-1/interleukin-8 and neutrophil elastase in a primate bacteremia model
-
Redl H, Schlag G, Bahrami S, Schade U, Ceska M, Stütz P. Plasma neutrophil-activating peptide-1/interleukin-8 and neutrophil elastase in a primate bacteremia model. J Infect Dis 1991;164:383-388
-
(1991)
J Infect Dis
, vol.164
, pp. 383-388
-
-
Redl, H.1
Schlag, G.2
Bahrami, S.3
Schade, U.4
Ceska, M.5
Stütz, P.6
-
50
-
-
0027953316
-
Differential effects of anti-tumor necrosis factor monoclonal antibodies on systemic inflammatory responses in experimental endotoxemia in chimpanzees
-
Van der Poll T, Levi M, van Deventer SJH, et al. Differential effects of anti-tumor necrosis factor monoclonal antibodies on systemic inflammatory responses in experimental endotoxemia in chimpanzees. Blood 1994;83:446-451
-
(1994)
Blood
, vol.83
, pp. 446-451
-
-
Van Der Poll, T.1
Levi, M.2
Van Deventer, S.J.H.3
-
51
-
-
0028323245
-
Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees
-
Van der Poll T, Levi M, Hack CE, et al. Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees. J Exp Med 1994;179:1253-1259
-
(1994)
J Exp Med
, vol.179
, pp. 1253-1259
-
-
Van Der Poll, T.1
Levi, M.2
Hack, C.E.3
-
52
-
-
0026772736
-
Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia
-
Fischer E, Marano MA, van Zee KJ, et al. Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia. J Clin Invest 1992;89: 1551-1557
-
(1992)
J Clin Invest
, vol.89
, pp. 1551-1557
-
-
Fischer, E.1
Marano, M.A.2
Van Zee, K.J.3
-
53
-
-
0026530738
-
Effects on leukocytes after injection of tumor necrosis factor into healthy humans
-
Van der Poll T, van Deventer SJH, Hack CE, et al. Effects on leukocytes after injection of tumor necrosis factor into healthy humans. Blood 1992;79:693-698
-
(1992)
Blood
, vol.79
, pp. 693-698
-
-
Van Der Poll, T.1
Van Deventer, S.J.H.2
Hack, C.E.3
-
54
-
-
0027506753
-
Endotoxin and tumor necrosis factor-α-induced interleukin-8 release in humans
-
Van Deventer SJH, Hart M, van der Poll T, Hack CE, Aarden LA. Endotoxin and tumor necrosis factor-α-induced interleukin-8 release in humans. J Infect Dis 1993;167:461-464
-
(1993)
J Infect Dis
, vol.167
, pp. 461-464
-
-
Van Deventer, S.J.H.1
Hart, M.2
Van Der Poll, T.3
Hack, C.E.4
Aarden, L.A.5
-
55
-
-
0027532975
-
Activation patterns of coagulation and fibrinolysis in baboons following infusion with lethal or sublethal dose of Escherichia coli
-
De Boer JP, Creasy AA, Chang A, et al. Activation patterns of coagulation and fibrinolysis in baboons following infusion with lethal or sublethal dose of Escherichia coli. Circ Shock 1993;39:59-67
-
(1993)
Circ Shock
, vol.39
, pp. 59-67
-
-
De Boer, J.P.1
Creasy, A.A.2
Chang, A.3
-
56
-
-
0021199320
-
Interleukin-1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells
-
Bevilacqua MP, Pober JS, Majeau GR, Cotran RS, Gimbrone MA Jr. Interleukin-1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J Exp Med 1984;160:618-623
-
(1984)
J Exp Med
, vol.160
, pp. 618-623
-
-
Bevilacqua, M.P.1
Pober, J.S.2
Majeau, G.R.3
Cotran, R.S.4
Gimbrone Jr., M.A.5
-
57
-
-
0022601049
-
Modulation of endothelial cell hemostatic properties by tumor necrosis factor
-
Nawroth PP, Stern DM. Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med 1986;163: 740-745
-
(1986)
J Exp Med
, vol.163
, pp. 740-745
-
-
Nawroth, P.P.1
Stern, D.M.2
-
58
-
-
0000555820
-
Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: Characterization and comparison with the actions of interleukin-1
-
Bevilacqua MP, Pober JS, Majeau GR, Fiers RW, Cotran RS, Gimbrone Jr MA. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin-1. Proc Natl Acad Sci USA 1986;83:4533-4537
-
(1986)
Proc Natl Acad Sci USA
, vol.83
, pp. 4533-4537
-
-
Bevilacqua, M.P.1
Pober, J.S.2
Majeau, G.R.3
Fiers, R.W.4
Cotran, R.S.5
Gimbrone Jr., M.A.6
-
59
-
-
0024545898
-
Tumor necrosis factor enhances expression of tissue factor mRNA in endothelial cells
-
Conway EM, Back R, Rosenberg RD, Koningsberg WH. Tumor necrosis factor enhances expression of tissue factor mRNA in endothelial cells. Thromb Res 1989;52:231-241
-
(1989)
Thromb Res
, vol.52
, pp. 231-241
-
-
Conway, E.M.1
Back, R.2
Rosenberg, R.D.3
Koningsberg, W.H.4
-
60
-
-
0023694658
-
Tumor necrosis lactor induces tissue factor-like activity in human leukemia cell line U937 and peripheral blood monocytes
-
Conkling PR, Greenberg CS, Weinberg JB. Tumor necrosis lactor induces tissue factor-like activity in human leukemia cell line U937 and peripheral blood monocytes. Blood 1988;72: 128-133
-
(1988)
Blood
, vol.72
, pp. 128-133
-
-
Conkling, P.R.1
Greenberg, C.S.2
Weinberg, J.B.3
-
61
-
-
2442724586
-
Interleukin-1 induces endothelial cell procoagulant while suppressing cell surface anticoagulant activity
-
Nawroth PP, Handley DA, Esmon CT, Stern DM. Interleukin-1 induces endothelial cell procoagulant while suppressing cell surface anticoagulant activity. Proc Natl Acad Sci USA 1986;83:3460-3464
-
(1986)
Proc Natl Acad Sci USA
, vol.83
, pp. 3460-3464
-
-
Nawroth, P.P.1
Handley, D.A.2
Esmon, C.T.3
Stern, D.M.4
-
62
-
-
0024589205
-
Tumor necrosis factor leads to the internalization and degradation of thrombomodulin from the surface of bovine endothelial cells in culture
-
Moore KL, Esmon CT, Esmon NL. Tumor necrosis factor leads to the internalization and degradation of thrombomodulin from the surface of bovine endothelial cells in culture. Blood 1989;73:159-165
-
(1989)
Blood
, vol.73
, pp. 159-165
-
-
Moore, K.L.1
Esmon, C.T.2
Esmon, N.L.3
-
63
-
-
0023755932
-
Tumor necrosis factor suppresses transcription of thrombomodulin gene in endothelial cells
-
Conway EM, Rosenberg RD. Tumor necrosis factor suppresses transcription of thrombomodulin gene in endothelial cells. Mol Cell Biol 1988;8:5588-5592
-
(1988)
Mol Cell Biol
, vol.8
, pp. 5588-5592
-
-
Conway, E.M.1
Rosenberg, R.D.2
-
64
-
-
0025963529
-
Regulation of thrombomodulin by tumor necrosis factor-α: Comparison of transcriptional and posttranscriptional mechanism
-
Lentz SR, Tsiang M, Sadler JE. Regulation of thrombomodulin by tumor necrosis factor-α: comparison of transcriptional and posttranscriptional mechanism. Blood 1991;77:542-550
-
(1991)
Blood
, vol.77
, pp. 542-550
-
-
Lentz, S.R.1
Tsiang, M.2
Sadler, J.E.3
-
65
-
-
0028174247
-
Tumor necrosis factor-α downregulates protein S secretion in human microvascular and umbilical vein endothelial cells but not in the HepG-2 hepatoma cell line
-
Hooper WC, Phillips DJ, Ribeiro MJA, et al. Tumor necrosis factor-α downregulates protein S secretion in human microvascular and umbilical vein endothelial cells but not in the HepG-2 hepatoma cell line. Blood 1994;84:483-489
-
(1994)
Blood
, vol.84
, pp. 483-489
-
-
Hooper, W.C.1
Phillips, D.J.2
Ribeiro, M.J.A.3
-
66
-
-
0025303041
-
Activation of coagulation after administration of tumor necrosis factor to normal subjects
-
Van der Poll T, Büller HR, ten Cate H, et al. Activation of coagulation after administration of tumor necrosis factor to normal subjects. N Engl J Med 1990;322:1622-1627
-
(1990)
N Engl J Med
, vol.322
, pp. 1622-1627
-
-
Van Der Poll, T.1
Büller, H.R.2
Ten Cate, H.3
-
67
-
-
0024319914
-
Tumor necrosis factor infusions have a procoagulant effect on the hemostatic mechanism of humans
-
Bauer KA, ten Cate H, Barzegar S, Spriggs DR, Sherman ML, Rosenberg RD. Tumor necrosis factor infusions have a procoagulant effect on the hemostatic mechanism of humans. Blood 1989;74:165-172
-
(1989)
Blood
, vol.74
, pp. 165-172
-
-
Bauer, K.A.1
Ten Cate, H.2
Barzegar, S.3
Spriggs, D.R.4
Sherman, M.L.5
Rosenberg, R.D.6
-
68
-
-
0025997956
-
Comparison of the early dynamics of coagulation activation after injection of endotoxin and tumor necrosis factor in healthy humans
-
Van der Poll T, van Deventer SJH, Büller HR, Sturk A, ten Cate JW. Comparison of the early dynamics of coagulation activation after injection of endotoxin and tumor necrosis factor in healthy humans. Prog Clin Biol Res 1991;367:55-60
-
(1991)
Prog Clin Biol Res
, vol.367
, pp. 55-60
-
-
Van Der Poll, T.1
Van Deventer, S.J.H.2
Büller, H.R.3
Sturk, A.4
Ten Cate, J.W.5
-
69
-
-
0025193590
-
Survival of primates in LD100 septic shock following therapy with antibody to tumor necrosis factor (TNF)
-
Hinshaw LB, Tekamp-Olson P, Chang ACK, et al. Survival of primates in LD100 septic shock following therapy with antibody to tumor necrosis factor (TNF). Circ Shock 1990;30: 279-292
-
(1990)
Circ Shock
, vol.30
, pp. 279-292
-
-
Hinshaw, L.B.1
Tekamp-Olson, P.2
Chang, A.C.K.3
-
70
-
-
0028706928
-
Studies on the inflammatory-coagulant axis in the baboon response to E. coli: Regulatory roles of protein C, S, C4bBP and of inhibitors of tissue factor
-
Taylor Jr FB. Studies on the inflammatory-coagulant axis in the baboon response to E. coli: regulatory roles of protein C, S, C4bBP and of inhibitors of tissue factor. Prog Clin Biol Res 1994;388:175-194
-
(1994)
Prog Clin Biol Res
, vol.388
, pp. 175-194
-
-
Taylor Jr., F.B.1
-
71
-
-
0029047379
-
2 in sepsis: Studies in nonhuman primates after interleukin-1α administration and during lethal bacteremia
-
2 in sepsis: Studies in nonhuman primates after interleukin-1α administration and during lethal bacteremia. Blood 1995;86:1027-1034
-
(1995)
Blood
, vol.86
, pp. 1027-1034
-
-
Jansen, P.M.1
Boermeester, M.A.2
Fischer, E.3
-
72
-
-
0029012382
-
Interleukin-1 blockade attenuates mediator release and dysregulation of the hemostatic mechanism during human sepsis
-
Boermeester MA, van Leeuwen PAM, Coyle SM, Wolbink GJ, Hack CF, Lowry SF. Interleukin-1 blockade attenuates mediator release and dysregulation of the hemostatic mechanism during human sepsis. Arch Surg 1995;130:739-748
-
(1995)
Arch Surg
, vol.130
, pp. 739-748
-
-
Boermeester, M.A.1
Van Leeuwen, P.A.M.2
Coyle, S.M.3
Wolbink, G.J.4
Hack, C.F.5
Lowry, S.F.6
-
73
-
-
0027162435
-
C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor
-
Cermak J, Key NS, Bach RR, Balla J, Jacob HS, Vercelotti GM. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 1993;82:513-520
-
(1993)
Blood
, vol.82
, pp. 513-520
-
-
Cermak, J.1
Key, N.S.2
Bach, R.R.3
Balla, J.4
Jacob, H.S.5
Vercelotti, G.M.6
-
74
-
-
0029743427
-
Factor VIIa and antithrombin III activity during severe sepsis and septic shock in neutropenic patients
-
Mesters RM, Mannucci PM, Coppola R, Keller T, Ostermann H, Kienast J. Factor VIIa and antithrombin III activity during severe sepsis and septic shock in neutropenic patients. Blood 1996;88:881-886
-
(1996)
Blood
, vol.88
, pp. 881-886
-
-
Mesters, R.M.1
Mannucci, P.M.2
Coppola, R.3
Keller, T.4
Ostermann, H.5
Kienast, J.6
-
75
-
-
0026788072
-
Protein C and S deficiency in severe infectious purpura of children: A collaborative study of 40 cases
-
Leclerc F, Hazelzet J, Jude B, et al. Protein C and S deficiency in severe infectious purpura of children: a collaborative study of 40 cases. Intensive Care Med 1992;18:202-205
-
(1992)
Intensive Care Med
, vol.18
, pp. 202-205
-
-
Leclerc, F.1
Hazelzet, J.2
Jude, B.3
-
77
-
-
0025095592
-
Thrombin versus plasmin generation in disseminated intravascular coagulation associated with various underlying disorders
-
Takahashi H, Tatewaki W, Wada K, Hanano M, Shibata A. Thrombin versus plasmin generation in disseminated intravascular coagulation associated with various underlying disorders. Am J Hematol 1990;33:90-95
-
(1990)
Am J Hematol
, vol.33
, pp. 90-95
-
-
Takahashi, H.1
Tatewaki, W.2
Wada, K.3
Hanano, M.4
Shibata, A.5
-
78
-
-
0026061609
-
Protein C, protein S and C4b-binding protein in severe infection and septic shock
-
Hesselvik JF, Malm J, Dahlbäck B, Blombäck M. Protein C, protein S and C4b-binding protein in severe infection and septic shock. Thromb Haemostas 1991;65:126-129
-
(1991)
Thromb Haemostas
, vol.65
, pp. 126-129
-
-
Hesselvik, J.F.1
Malm, J.2
Dahlbäck, B.3
Blombäck, M.4
-
79
-
-
0029562092
-
Activation of the intrinsic pathway of coagulation in children with meningococcal septic shock
-
Wuillemin WA, Fijnvandraat K, Derkx BHF, et al. Activation of the intrinsic pathway of coagulation in children with meningococcal septic shock. Thromb Haemostas 1995;74: 1436-1441
-
(1995)
Thromb Haemostas
, vol.74
, pp. 1436-1441
-
-
Wuillemin, W.A.1
Fijnvandraat, K.2
Derkx, B.H.F.3
-
80
-
-
0029011240
-
Activation of the protein C pathway in acute sepsis
-
Alcaraz A, España F, Sánchez-Cuenca J, et al. Activation of the protein C pathway in acute sepsis. Thromb Res 1995;79: 83-93
-
(1995)
Thromb Res
, vol.79
, pp. 83-93
-
-
Alcaraz, A.1
España, F.2
Sánchez-Cuenca, J.3
-
81
-
-
0025854940
-
Fibrinolysis and coagulation in patients with infectious disease and sepsis
-
Philippé J, Offner F, Declerck PJ, et al. Fibrinolysis and coagulation in patients with infectious disease and sepsis. Thromb Haemostas 1991;65:291-295
-
(1991)
Thromb Haemostas
, vol.65
, pp. 291-295
-
-
Philippé, J.1
Offner, F.2
Declerck, P.J.3
-
82
-
-
0019917301
-
Studies of components of the coagulation systems in normal individuals and septic shock patients
-
Smith-Erichsen N, Aasen AO, Gallimore MJ, Amundsen E. Studies of components of the coagulation systems in normal individuals and septic shock patients. Circ Shock 1982;9:491-497
-
(1982)
Circ Shock
, vol.9
, pp. 491-497
-
-
Smith-Erichsen, N.1
Aasen, A.O.2
Gallimore, M.J.3
Amundsen, E.4
-
83
-
-
0022395406
-
1-antitrypsin, antithrombin and the mechanism of inflammatory thrombosis
-
1-antitrypsin, antithrombin and the mechanism of inflammatory thrombosis. Nature 1985;317:730-732
-
(1985)
Nature
, vol.317
, pp. 730-732
-
-
Carrell, R.W.1
Owen, M.C.2
-
84
-
-
0024340631
-
Inactivation of human antithrombin by neutrophil elastase. Kinetics of the heparin-dependent reaction
-
Jordan RE, Nelson RM, Kilpatrick J, Newgren JO, Esmon PC, Fournel MA. Inactivation of human antithrombin by neutrophil elastase. Kinetics of the heparin-dependent reaction. J Biol Chem 1989;264:10493-10500
-
(1989)
J Biol Chem
, vol.264
, pp. 10493-10500
-
-
Jordan, R.E.1
Nelson, R.M.2
Kilpatrick, J.3
Newgren, J.O.4
Esmon, P.C.5
Fournel, M.A.6
-
85
-
-
0025071513
-
Meningococcemia and purpura fulminans in adults: Acute deficiencies of proteins C and S and early treatment with antithrombin III concentrates
-
Fourrier F, Lestavel P, Chopin C, et al. Meningococcemia and purpura fulminans in adults: acute deficiencies of proteins C and S and early treatment with antithrombin III concentrates. Intensive Care Med 1990;16:121-124
-
(1990)
Intensive Care Med
, vol.16
, pp. 121-124
-
-
Fourrier, F.1
Lestavel, P.2
Chopin, C.3
-
86
-
-
0021863658
-
Serial studies of protein C and its plasma inhibitor in patients with disseminated intravascular coagulation
-
Marlar RA, Endres-Brooks J, Miller C. Serial studies of protein C and its plasma inhibitor in patients with disseminated intravascular coagulation. Blood 1985;66:59-63
-
(1985)
Blood
, vol.66
, pp. 59-63
-
-
Marlar, R.A.1
Endres-Brooks, J.2
Miller, C.3
-
87
-
-
0024323137
-
Human plasma extrinsic pathway inhibitor activity: II. Plasma levels in disseminated intravascular coagulation and hepatocellular disease
-
Warr TA, Rao LVM, Rapaport SI. Human plasma extrinsic pathway inhibitor activity: II. Plasma levels in disseminated intravascular coagulation and hepatocellular disease. Blood 1989;74:994-998
-
(1989)
Blood
, vol.74
, pp. 994-998
-
-
Warr, T.A.1
Rao, L.V.M.2
Rapaport, S.I.3
-
88
-
-
0016291127
-
Direct evidence for Hageman factor (factor XII) activation by bacterial lipopolysaccharides (endotoxins)
-
Morrison DC, Cochrane CG. Direct evidence for Hageman factor (factor XII) activation by bacterial lipopolysaccharides (endotoxins). J Exp Med 1974;140:797-802
-
(1974)
J Exp Med
, vol.140
, pp. 797-802
-
-
Morrison, D.C.1
Cochrane, C.G.2
-
89
-
-
0027180991
-
Activation of the kallikrein-kinin system after endotoxin administration to normal human volunteers
-
Dela Cadena RA, Suffredini AF, Page JD, et al. Activation of the kallikrein-kinin system after endotoxin administration to normal human volunteers. Blood 1993;91:3313-3317
-
(1993)
Blood
, vol.91
, pp. 3313-3317
-
-
Dela Cadena, R.A.1
Suffredini, A.F.2
Page, J.D.3
-
90
-
-
0021871268
-
Activation and inhibition of Hageman factor-dependent pathways and the complement system in uncomplicated bacteremia or bacterial shock
-
Kalter HJ, Daha MR, ten Cate JW, Verhoef J, Bouma BN. Activation and inhibition of Hageman factor-dependent pathways and the complement system in uncomplicated bacteremia or bacterial shock. J Infect Dis 1985;151:1019-1027
-
(1985)
J Infect Dis
, vol.151
, pp. 1019-1027
-
-
Kalter, H.J.1
Daha, M.R.2
Ten Cate, J.W.3
Verhoef, J.4
Bouma, B.N.5
-
91
-
-
0024234533
-
Quantification of plasma factor XIIa-C1-inhibitor and kallikrein-C1-inhibitor complexes in sepsis
-
Nuijens JH, Huijbregts CC, Eerenberg-Belmer AJ, et al. Quantification of plasma factor XIIa-C1-inhibitor and kallikrein-C1-inhibitor complexes in sepsis. Blood 1988;72:1841-1848
-
(1988)
Blood
, vol.72
, pp. 1841-1848
-
-
Nuijens, J.H.1
Huijbregts, C.C.2
Eerenberg-Belmer, A.J.3
-
93
-
-
0030761483
-
Interleukin-6 downregulates factor XII production by human hepatoma cell line (HepG2)
-
Citarella F, Felici A, Brouwer M, Wagstaff J, Fantoni A, Hack CE. Interleukin-6 downregulates factor XII production by human hepatoma cell line (HepG2). Blood 1997;90:1501-1507
-
(1997)
Blood
, vol.90
, pp. 1501-1507
-
-
Citarella, F.1
Felici, A.2
Brouwer, M.3
Wagstaff, J.4
Fantoni, A.5
Hack, C.E.6
-
94
-
-
0026524251
-
Activation of the contact system in lethal hypotensive bacteremia in a baboon model
-
Pixley RA, DeLa Cadena RA, Page JD, et al. Activation of the contact system in lethal hypotensive bacteremia in a baboon model. Am J Pathol 1992;140:897-906
-
(1992)
Am J Pathol
, vol.140
, pp. 897-906
-
-
Pixley, R.A.1
DeLa Cadena, R.A.2
Page, J.D.3
-
95
-
-
13344290505
-
Endothelium-dependent and independent response to vasoactive substances of isolated human coronary artery
-
Toda N, Okamura T. Endothelium-dependent and independent response to vasoactive substances of isolated human coronary artery. Am J Physiol 1992;262:H995-H999
-
(1992)
Am J Physiol
, vol.262
-
-
Toda, N.1
Okamura, T.2
-
96
-
-
0018940298
-
Effect of bradykinin and thrombin on prostacyclin synthesis in endothelial cells from calf and pig aorta and human umbilical cord vein
-
Hong SL. Effect of bradykinin and thrombin on prostacyclin synthesis in endothelial cells from calf and pig aorta and human umbilical cord vein. Thromb Res 1980;18:787-791
-
(1980)
Thromb Res
, vol.18
, pp. 787-791
-
-
Hong, S.L.1
-
97
-
-
0029986326
-
Inhibition of factor XII in septic baboons attenuates the activation of complement and fibrinolytic systems and reduces the release of interleukin-6 and neutrophil elastase
-
Jansen PM, Pixley RA, Brouwer M, et al. Inhibition of factor XII in septic baboons attenuates the activation of complement and fibrinolytic systems and reduces the release of interleukin-6 and neutrophil elastase. Blood 1996;87:2337-2344
-
(1996)
Blood
, vol.87
, pp. 2337-2344
-
-
Jansen, P.M.1
Pixley, R.A.2
Brouwer, M.3
-
99
-
-
0023130521
-
Plasminogen activator inhibitors
-
Sprengers ED, Kluft C. Plasminogen activator inhibitors. Blood 1987;69:381-387
-
(1987)
Blood
, vol.69
, pp. 381-387
-
-
Sprengers, E.D.1
Kluft, C.2
-
100
-
-
0024247054
-
Fibrinolytic system of vascular endothelial cells. Role of plasminogen activator inhibitors
-
Schleef RR, Loskutoff DJ. Fibrinolytic system of vascular endothelial cells. Role of plasminogen activator inhibitors. Haemostasis 1988;18:328-341
-
(1988)
Haemostasis
, vol.18
, pp. 328-341
-
-
Schleef, R.R.1
Loskutoff, D.J.2
-
101
-
-
0029588419
-
Inhibitors of plasminogen activator in neutrophils and mononuclear cells from septic patients
-
Haj MA, Robbie LA, Adey GD, Bennett B. Inhibitors of plasminogen activator in neutrophils and mononuclear cells from septic patients. Thromb Haemostas 1995;74:1528-1532
-
(1995)
Thromb Haemostas
, vol.74
, pp. 1528-1532
-
-
Haj, M.A.1
Robbie, L.A.2
Adey, G.D.3
Bennett, B.4
-
102
-
-
0030010186
-
Disseminated intravascular coagulation: Objective clinical and laboratory diagnosis, treatment, and assessment of therapeutic response
-
Bick RL. Disseminated intravascular coagulation: objective clinical and laboratory diagnosis, treatment, and assessment of therapeutic response. Semin Thromb Hemostas 1996;22: 69-88
-
(1996)
Semin Thromb Hemostas
, vol.22
, pp. 69-88
-
-
Bick, R.L.1
-
103
-
-
0024562002
-
Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects
-
Suffredini AF, Harpel PC, Parrillo JE. Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects. N Engl J Med 1989;320:1165-1172
-
(1989)
N Engl J Med
, vol.320
, pp. 1165-1172
-
-
Suffredini, A.F.1
Harpel, P.C.2
Parrillo, J.E.3
-
104
-
-
0029041753
-
Plasminogen activator and plasminogen activator inhibitor 1 release during experimental endotoxaemia in chimpanzees: Effect of interventions in the cytokine and coagulation cascades
-
Biemond BJ, Levi M, ten Cate H, et al. Plasminogen activator and plasminogen activator inhibitor 1 release during experimental endotoxaemia in chimpanzees: effect of interventions in the cytokine and coagulation cascades. Clin Science 1995;88:587-594
-
(1995)
Clin Science
, vol.88
, pp. 587-594
-
-
Biemond, B.J.1
Levi, M.2
Ten Cate, H.3
-
105
-
-
0025838097
-
Fibrinolytic response to tumor necrosis factor in healthy subjects
-
van der Poll T, Levi M, Büller HR, et al. Fibrinolytic response to tumor necrosis factor in healthy subjects. J Exp Med 1991;174:729-732
-
(1991)
J Exp Med
, vol.174
, pp. 729-732
-
-
Van Der Poll, T.1
Levi, M.2
Büller, H.R.3
-
106
-
-
0025224751
-
Progress of fibrinolysis during tumor necrosis factor infusions in humans. Concomitant increase in tissue-type plasminogen activator, plasminogen activator inhibitor type-1, and fibrin(ogen) degradation products
-
van Hinsbergh VW, Bauer KA, Kooistra T, et al. Progress of fibrinolysis during tumor necrosis factor infusions in humans. Concomitant increase in tissue-type plasminogen activator, plasminogen activator inhibitor type-1, and fibrin(ogen) degradation products. Blood 1990;76:2284-2289
-
(1990)
Blood
, vol.76
, pp. 2284-2289
-
-
Van Hinsbergh, V.W.1
Bauer, K.A.2
Kooistra, T.3
-
107
-
-
0023875704
-
Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor
-
Schleef RR, Bevilacqua MP, Sawdey M, Gimbrone MA Jr, Loskutoff DJ. Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor. J Biol Chem 1988;263: 5797-5803
-
(1988)
J Biol Chem
, vol.263
, pp. 5797-5803
-
-
Schleef, R.R.1
Bevilacqua, M.P.2
Sawdey, M.3
Gimbrone Jr., M.A.4
Loskutoff, D.J.5
-
108
-
-
0022536999
-
Regulation of the fibrinolytic system of cultured human vascular endothelium by interleukin 1
-
Bevilacqua MP, Schleef RR, Gimbrone MA Jr, Loskutoff DJ. Regulation of the fibrinolytic system of cultured human vascular endothelium by interleukin 1. J Clin Invest 1986;78: 587-591
-
(1986)
J Clin Invest
, vol.78
, pp. 587-591
-
-
Bevilacqua, M.P.1
Schleef, R.R.2
Gimbrone Jr., M.A.3
Loskutoff, D.J.4
-
109
-
-
0025331306
-
Tumor necrosis factor induces the production of urokinase-type plasminogen activator by human endothelial cells
-
van Hinsbergh VW, van den Berg EA, Fiers W, Dooijewaard G. Tumor necrosis factor induces the production of urokinase-type plasminogen activator by human endothelial cells. Blood 1990;75:1991-1998
-
(1990)
Blood
, vol.75
, pp. 1991-1998
-
-
Van Hinsbergh, V.W.1
Van Den Berg, E.A.2
Fiers, W.3
Dooijewaard, G.4
-
110
-
-
45949121083
-
Secretion of tissue-type plasminogen activator and plasminogen activator inhibitor by cultured human endothelial cells: Modulation by thrombin, endotoxin, and histamine
-
Hanss M, Collen D. Secretion of tissue-type plasminogen activator and plasminogen activator inhibitor by cultured human endothelial cells: modulation by thrombin, endotoxin, and histamine. J Lab Clin Med 1987;109:97-104
-
(1987)
J Lab Clin Med
, vol.109
, pp. 97-104
-
-
Hanss, M.1
Collen, D.2
-
111
-
-
0025181049
-
Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissues in vivo
-
Quax PH, van den Hoogen CM, Verheijen JH, et al. Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissues in vivo. J Biol Chem 1990;265:15560-15563
-
(1990)
J Biol Chem
, vol.265
, pp. 15560-15563
-
-
Quax, P.H.1
Van Den Hoogen, C.M.2
Verheijen, J.H.3
-
112
-
-
0025949379
-
Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-alpha, and transforming growth factor-beta
-
Sawdey MS, Loskutoff DJ. Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-alpha, and transforming growth factor-beta. J Clin Invest 1991;88:1346-1353
-
(1991)
J Clin Invest
, vol.88
, pp. 1346-1353
-
-
Sawdey, M.S.1
Loskutoff, D.J.2
-
113
-
-
0020472522
-
Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin
-
Hoylaerts M, Rijken DC, Lijnen HR, Collen D. Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin. J Biol Chem 1982;257:2912-2919
-
(1982)
J Biol Chem
, vol.257
, pp. 2912-2919
-
-
Hoylaerts, M.1
Rijken, D.C.2
Lijnen, H.R.3
Collen, D.4
-
114
-
-
0025360023
-
The fibrinolytic potential of the normal primate following the generation of thrombin in vivo
-
Giles AR, Nesheim ME, Herring SE, Hoogendoorn H, Stumb DC, Heldebrandt CM. The fibrinolytic potential of the normal primate following the generation of thrombin in vivo. Thromb Haemostas 1990;63:476-481
-
(1990)
Thromb Haemostas
, vol.63
, pp. 476-481
-
-
Giles, A.R.1
Nesheim, M.E.2
Herring, S.E.3
Hoogendoorn, H.4
Stumb, D.C.5
Heldebrandt, C.M.6
-
115
-
-
0026050749
-
Reduction of contact activation related fibrinolytic activity in factor XII deficient patients. Further evidence for the role of the contact system in fibrinolysis in vivo
-
Levi M, Hack CE, de Boer JP, Brandjes DP, Buller HR, ten Cate JW. Reduction of contact activation related fibrinolytic activity in factor XII deficient patients. Further evidence for the role of the contact system in fibrinolysis in vivo. J Clin Invest 1991;88:1155-1160
-
(1991)
J Clin Invest
, vol.88
, pp. 1155-1160
-
-
Levi, M.1
Hack, C.E.2
De Boer, J.P.3
Brandjes, D.P.4
Buller, H.R.5
Ten Cate, J.W.6
-
116
-
-
0030175321
-
Activation of the contact and fibrinolytic systems after intravenous administration of endotoxin to normal human volunteers: Correlation with the cytokine profile
-
DeLa Cadena RA, Majluf-Cruz A, Stadnicki A, Agosti JM, Colman RW, Suffredini AF. Activation of the contact and fibrinolytic systems after intravenous administration of endotoxin to normal human volunteers: correlation with the cytokine profile. Immunopharmacology 1996;33:231-237
-
(1996)
Immunopharmacology
, vol.33
, pp. 231-237
-
-
DeLa Cadena, R.A.1
Majluf-Cruz, A.2
Stadnicki, A.3
Agosti, J.M.4
Colman, R.W.5
Suffredini, A.F.6
-
117
-
-
0029855166
-
Increase of plasminogen activator inhibitor levels predicts outcome of leukocytopenic patients with sepsis
-
Mesters RM, Florke N, Ostermann H, Kienast J. Increase of plasminogen activator inhibitor levels predicts outcome of leukocytopenic patients with sepsis. Thromb Haemostas 1996;75:902-907
-
(1996)
Thromb Haemostas
, vol.75
, pp. 902-907
-
-
Mesters, R.M.1
Florke, N.2
Ostermann, H.3
Kienast, J.4
-
118
-
-
0029078829
-
Influence of white blood cells on the fibrinolytic response to sepsis: Studies of septic patients with or without severe leukopenia
-
Haj MA, Neilly IJ, Robbie LA, Adey GD, Bennett B. Influence of white blood cells on the fibrinolytic response to sepsis: studies of septic patients with or without severe leukopenia. Br J Haematol 1995;90:541-547
-
(1995)
Br J Haematol
, vol.90
, pp. 541-547
-
-
Haj, M.A.1
Neilly, I.J.2
Robbie, L.A.3
Adey, G.D.4
Bennett, B.5
-
119
-
-
0023907147
-
Plasminogen activator inhibitor activity in bacterial infection
-
Paramo JA, Fernandez Diaz FJ, Rocha E. Plasminogen activator inhibitor activity in bacterial infection. Thromb Haemostas 1988;59:451-454
-
(1988)
Thromb Haemostas
, vol.59
, pp. 451-454
-
-
Paramo, J.A.1
Fernandez Diaz, F.J.2
Rocha, E.3
-
120
-
-
0023547682
-
Tissue plasminogen activator antigen and activity in disseminated intravascular coagulation: Clinicopathologic correlations
-
Francis RB Jr, Seyfert U. Tissue plasminogen activator antigen and activity in disseminated intravascular coagulation: clinicopathologic correlations. J Lab Clin Med 1987;110:541-547
-
(1987)
J Lab Clin Med
, vol.110
, pp. 541-547
-
-
Francis Jr., R.B.1
Seyfert, U.2
-
121
-
-
0026083292
-
Changes in plasma levels of tissue-plasminogen activator/inhibitor complex and active plasminogen activator inhibitor in patients with disseminated intravascular coagulation
-
Asakura H, Jokaji H, Saito M, et al. Changes in plasma levels of tissue-plasminogen activator/inhibitor complex and active plasminogen activator inhibitor in patients with disseminated intravascular coagulation. Am J Hematol 1991;36:176-183
-
(1991)
Am J Hematol
, vol.36
, pp. 176-183
-
-
Asakura, H.1
Jokaji, H.2
Saito, M.3
-
122
-
-
0025165017
-
Plasminogen activator inhibitor 1 and 2, alpha-2-antiplasmin, plasminogen, and endotoxin levels in systemic meningococcal disease
-
Brandtzaeg P, Joo GB, Brusletto B, Kierulf P. Plasminogen activator inhibitor 1 and 2, alpha-2-antiplasmin, plasminogen, and endotoxin levels in systemic meningococcal disease. Thromb Res 1990;57:271-278
-
(1990)
Thromb Res
, vol.57
, pp. 271-278
-
-
Brandtzaeg, P.1
Joo, G.B.2
Brusletto, B.3
Kierulf, P.4
-
123
-
-
0023697144
-
Plasmin-alpha 2-plasmin inhibitor complex in plasma of patients with disseminated intravascular coagulation
-
Takahashi H, Hanano M, Takizawa S, Tatewaki W, Shibata A. Plasmin-alpha 2-plasmin inhibitor complex in plasma of patients with disseminated intravascular coagulation. Am J Hematol 1988;28:162-166
-
(1988)
Am J Hematol
, vol.28
, pp. 162-166
-
-
Takahashi, H.1
Hanano, M.2
Takizawa, S.3
Tatewaki, W.4
Shibata, A.5
-
124
-
-
0028127109
-
Study of the balance between coagulation and fibrinolysis in disseminated intravascular coagulation using molecular markers
-
Asakura H, Jokaji H, Saito M, et al. Study of the balance between coagulation and fibrinolysis in disseminated intravascular coagulation using molecular markers. Blood Coag Fibrinolysis 1994;5:829-832
-
(1994)
Blood Coag Fibrinolysis
, vol.5
, pp. 829-832
-
-
Asakura, H.1
Jokaji, H.2
Saito, M.3
-
125
-
-
0027419710
-
Evolution of plasminogen activator inhibitor type 1 in patients with septic shock - Correlation with cytokine concentrations
-
Kruithof EKO, Calandra T, Pralong G, et al. Evolution of plasminogen activator inhibitor type 1 in patients with septic shock - Correlation with cytokine concentrations. Fibrinolysis 1993;7:117-121
-
(1993)
Fibrinolysis
, vol.7
, pp. 117-121
-
-
Kruithof, E.K.O.1
Calandra, T.2
Pralong, G.3
-
126
-
-
0025806257
-
Role of leukocytes in the activation of intravascular coagulation in patients with septicemia
-
Okajima K, Yang WP, Okabe H, Inoue M, Takatsuki K. Role of leukocytes in the activation of intravascular coagulation in patients with septicemia. Am J Hematol 1991;36:265-271
-
(1991)
Am J Hematol
, vol.36
, pp. 265-271
-
-
Okajima, K.1
Yang, W.P.2
Okabe, H.3
Inoue, M.4
Takatsuki, K.5
-
127
-
-
0021986774
-
Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation
-
Colucci M, Paramo JA, Collen D. Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation. J Clin Invest 1985;75:818-824
-
(1985)
J Clin Invest
, vol.75
, pp. 818-824
-
-
Colucci, M.1
Paramo, J.A.2
Collen, D.3
-
128
-
-
0023727896
-
Tumor necrosis factor increases the production of plasminogen activator inhibitor in human endothelial cells in vitro and in rats in vivo
-
van Hinsbergh VW, Kooistra T, van den Berg EA, Princen HM, Fiers W, Emeis JJ. Tumor necrosis factor increases the production of plasminogen activator inhibitor in human endothelial cells in vitro and in rats in vivo. Blood 1988;72: 1467-1473
-
(1988)
Blood
, vol.72
, pp. 1467-1473
-
-
Van Hinsbergh, V.W.1
Kooistra, T.2
Van Den Berg, E.A.3
Princen, H.M.4
Fiers, W.5
Emeis, J.J.6
-
129
-
-
0022525897
-
Interleukin-1 and lipopolysaccharide induce an inhibitor of tissue-type plasminogen activator in vivo and in cultured endothelial cells
-
Emeis JJ, Kooistra T. Interleukin-1 and lipopolysaccharide induce an inhibitor of tissue-type plasminogen activator in vivo and in cultured endothelial cells. J Exp Med 1986;163: 1260-1266
-
(1986)
J Exp Med
, vol.163
, pp. 1260-1266
-
-
Emeis, J.J.1
Kooistra, T.2
-
130
-
-
0022599303
-
Thrombin induction of plasminogen activator-inhibitor in cultured human endothelial cells
-
Gelehrter TD, Sznycer-Laszuk R. Thrombin induction of plasminogen activator-inhibitor in cultured human endothelial cells. J Clin Invest 1986;77:165-169
-
(1986)
J Clin Invest
, vol.77
, pp. 165-169
-
-
Gelehrter, T.D.1
Sznycer-Laszuk, R.2
-
131
-
-
0027291105
-
Transferable lipids in oxidized low-density lipoprotein stimulate plasminogen activator inhibitor-1 and inhibit tissue-type plasminogen activator release from endothelial cells
-
Kugiyama K, Sakamoto T, Misumi I, et al. Transferable lipids in oxidized low-density lipoprotein stimulate plasminogen activator inhibitor-1 and inhibit tissue-type plasminogen activator release from endothelial cells. Circ Res 1993;73:335-343
-
(1993)
Circ Res
, vol.73
, pp. 335-343
-
-
Kugiyama, K.1
Sakamoto, T.2
Misumi, I.3
-
132
-
-
0025827561
-
Augmentation of synthesis of plasminogen activator inhibitor type 1 by insulin and insulin-like growth factor type I: Implications for vascular disease in hyperinsulinemic states
-
published erratum appears in Proc Natl Acad Sci USA 1992;89(3):1148
-
Schneider DJ, Sobel BE. Augmentation of synthesis of plasminogen activator inhibitor type 1 by insulin and insulin-like growth factor type I: implications for vascular disease in hyperinsulinemic states [published erratum appears in Proc Natl Acad Sci USA 1992;89(3):1148]. Proc Nat Acad Sci USA 1991;88:9959-9963
-
(1991)
Proc Nat Acad Sci USA
, vol.88
, pp. 9959-9963
-
-
Schneider, D.J.1
Sobel, B.E.2
-
133
-
-
0009060192
-
Effects of hormone-replacement therapy on fibrinolysis in post-menopausal women
-
Koh KK, Mincemoyer R, Bui MN, et al. Effects of hormone-replacement therapy on fibrinolysis in post-menopausal women. N Engl J Med 1997;336:683-690
-
(1997)
N Engl J Med
, vol.336
, pp. 683-690
-
-
Koh, K.K.1
Mincemoyer, R.2
Bui, M.N.3
-
134
-
-
0025766634
-
Lipoprotein (a) regulates plasminogen activator inhibitor-1 expression in endothelial cells. A potential mechanism in thrombogenesis
-
Etingin OR, Hajjar DP, Hajjar KA, Harpel PC, Nachman RL. Lipoprotein (a) regulates plasminogen activator inhibitor-1 expression in endothelial cells. A potential mechanism in thrombogenesis. J Biol Chem 1991;266:2459-2465
-
(1991)
J Biol Chem
, vol.266
, pp. 2459-2465
-
-
Etingin, O.R.1
Hajjar, D.P.2
Hajjar, K.A.3
Harpel, P.C.4
Nachman, R.L.5
-
135
-
-
0024308313
-
Plasminogen activator inhibitor 1: A new prognostic marker in septic shock
-
Pralong G, Calandra T, Glauser MP, et al. Plasminogen activator inhibitor 1: a new prognostic marker in septic shock. Thromb Haemostas 1989;61:459-162
-
(1989)
Thromb Haemostas
, vol.61
, pp. 459-1162
-
-
Pralong, G.1
Calandra, T.2
Glauser, M.P.3
-
136
-
-
0029876674
-
Disseminated intravascular coagulation is a frequent complication of systemic inflammatory response syndrome
-
Gando S, Kameue T, Nanzaki S, Nakanishi Y. Disseminated intravascular coagulation is a frequent complication of systemic inflammatory response syndrome. Thromb Haemostas 1996;75:224-228
-
(1996)
Thromb Haemostas
, vol.75
, pp. 224-228
-
-
Gando, S.1
Kameue, T.2
Nanzaki, S.3
Nakanishi, Y.4
-
137
-
-
0028933153
-
Haemostatic and fibrinolytic parameters in septic patients with leukopenia or leukocytosis
-
Saito M, Asakura H, Jokaji H, et al. Haemostatic and fibrinolytic parameters in septic patients with leukopenia or leukocytosis. Eur J Haematol 1995;54:176-179
-
(1995)
Eur J Haematol
, vol.54
, pp. 176-179
-
-
Saito, M.1
Asakura, H.2
Jokaji, H.3
-
138
-
-
0023574958
-
Plasminogen activator inhibitor 1: Development of a radioimmunoassay and observations on its plasma concentration during venous occlusion and after platelet aggregation
-
Kruithof EK, Nicolosa G, Bachmann F. Plasminogen activator inhibitor 1: development of a radioimmunoassay and observations on its plasma concentration during venous occlusion and after platelet aggregation. Blood 1987;70:1645-1653
-
(1987)
Blood
, vol.70
, pp. 1645-1653
-
-
Kruithof, E.K.1
Nicolosa, G.2
Bachmann, F.3
-
139
-
-
0022243864
-
Endothelial cells produce a latent inhibitor of plasminogen that can be associated by denaturants
-
Hekman CM, Loskutoff DJ. Endothelial cells produce a latent inhibitor of plasminogen that can be associated by denaturants. J Biol Chem 1989;260:11581-11587
-
(1989)
J Biol Chem
, vol.260
, pp. 11581-11587
-
-
Hekman, C.M.1
Loskutoff, D.J.2
-
141
-
-
0023876027
-
Plasminogen activator inhibitor type 1: Biochemical, biological and clinical aspects
-
Kruithof EKO. Plasminogen activator inhibitor type 1: biochemical, biological and clinical aspects. Fibrinolysis 1988; 2:59-70
-
(1988)
Fibrinolysis
, vol.2
, pp. 59-70
-
-
Kruithof, E.K.O.1
-
142
-
-
0025687479
-
Oxidation susceptibility of plasminogen activator inhibitors in human plasma
-
Stief TW, Martin E, Caso F, Rodriquez JM. Oxidation susceptibility of plasminogen activator inhibitors in human plasma. Thromb Res 1990;60:177-180
-
(1990)
Thromb Res
, vol.60
, pp. 177-180
-
-
Stief, T.W.1
Martin, E.2
Caso, F.3
Rodriquez, J.M.4
-
143
-
-
0029867731
-
A clinical study on the significance of platelet-activating factor in the pathophysiology of septic disseminated intravascular coagulation in surgery
-
Ono S, Mochizuli H, Tamakuma S. A clinical study on the significance of platelet-activating factor in the pathophysiology of septic disseminated intravascular coagulation in surgery. Am J Surg 1996;171:409-415
-
(1996)
Am J Surg
, vol.171
, pp. 409-415
-
-
Ono, S.1
Mochizuli, H.2
Tamakuma, S.3
-
144
-
-
0024344607
-
Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome
-
Idell S, James KK, Levin EG, et al. Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome. J Clin Invest 1989;84:695-705
-
(1989)
J Clin Invest
, vol.84
, pp. 695-705
-
-
Idell, S.1
James, K.K.2
Levin, E.G.3
-
145
-
-
0025318632
-
Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome
-
Bertozzi P, Astedt B, Zenzius L, et al. Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome. N Engl J Med 1990;322:890-897.
-
(1990)
N Engl J Med
, vol.322
, pp. 890-897
-
-
Bertozzi, P.1
Astedt, B.2
Zenzius, L.3
|